| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10904496 | Experimental Cell Research | 2012 | 14 Pages |
Abstract
⺠Survivin shRNA + EGCG controlled growth of human malignant neuroblastoma cells. ⺠Survivin knockdown induced neuronal differentiation in neuroblastoma cells. ⺠Survivin shRNA + EGCG induced morphological and biochemical features of apoptosis. ⺠Combination therapy inhibited invasion, proliferation, and angiogenesis as well. ⺠So, combination therapy showed multiple anti-cancer mechanisms in neuroblastoma.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Md. Motarab Hossain, Naren L. Banik, Swapan K. Ray,